News

Published on 7 May 2024 on Benzinga

FibroGen Shares Climb On Strong Q1 Sales - FibroGen (NASDAQ:FGEN)

Article preview image

FibroGen, Inc. FGEN shares are trading higher Tuesday after the company posted mixed first-quarter financial results. Here's a look at the key figures from the report. 

The Details:

Read the rest of the article
NASDAQ.FGEN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Favourable Signals For FibroGen: Numerous Insiders Acquired Stock

Generally, when a single insider buys stock, it is usually not a big deal. However, when several ...

Simply Wall St. · via Yahoo Finance 19 Jun 2024
FibroGen Shares Climb On Strong Q1 Sales - FibroGen (NASDAQ:FGEN)

FibroGen, Inc. FGEN shares are trading higher Tuesday after the company posted mixed first-quarte...

Benzinga 7 May 2024
Earnings call: FibroGen reports Q1 2024 results, optimistic about pipeline By Investing.com

FibroGen, Inc. (NASDAQ:FGEN) has reported its financial results for the first quarter of 2024,...

Investing.com 7 May 2024
FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript

FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript May 6, 2024 FibroGen, Inc. misses o...

Insider Monkey via Yahoo Finance 7 May 2024
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day...

Shares of Beyond, Inc. BYON fell sharply during Tuesday’s session following weaker-than-expected ...

Benzinga 7 May 2024
Cardiff (CRDF) Stock Rallies 194% in a Month: Here's Why

Cardiff Oncology, Inc. CRDF is developing novel therapeutic candidates to treat various types of ...

Zacks via Yahoo Finance 21 Mar 2024
Crinetics (CRNX) Up as Second Acromegaly Study Meets Goals

Crinetics Pharmaceuticals’ CRNX shares gained 19.1% on Mar 19 after the company reported positive...

Zacks via Yahoo Finance 20 Mar 2024
3 Nightmare Nasdaq Stocks Not Worth Holding Another Day

Sensible investors can identify potential issues from declining financial reports, brewing servic...

InvestorPlace 20 Mar 2024
Mirum's (MIRM) Livmarli Receives FDA Nod for Expanded Use

Mirum Pharmaceuticals, Inc. MIRM announced that the FDA had approved a label expansion for Livmar...

Zacks via Yahoo Finance 15 Mar 2024
AstraZeneca (AZN) to Acquire Amolyt Pharma for $1.05 Billion

AstraZeneca AZN announced that it has entered into a definitive agreement to acquire Amolyt Pharm...

Zacks via Yahoo Finance 14 Mar 2024

Copyright Statfolio @ 2024

Social Accounts